# SENTINEL : Impact of the Use of a Web-application for the Detection of Lung Cancer Relapse

> **NCT02361099** · PHASE3 · COMPLETED · sponsor: **Weprom** · enrollment: 133 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **OTHER:** Monitoring by SENTINEL application

## Key facts

- **NCT ID:** NCT02361099
- **Lead sponsor:** Weprom
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-03
- **Primary completion:** 2017-12
- **Final completion:** 2018-03
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2020-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02361099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02361099, "SENTINEL : Impact of the Use of a Web-application for the Detection of Lung Cancer Relapse". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02361099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*